Medivolve Announces Investment Into Marvel Diagnostics and Its Non-Invasive Exhaled Breath Diagnostic Technology

Author's Avatar
Jan 28, 2021
Article's Main Image

Marvel Diagnostics innovative BlowFISH technology offers the potential for a a simple, inexpensive, non-invasive, massively-deployable, rapid diagnostic or sentinel system for detecting respiratory illness and airborne viral threats.